Archive: Mobile Healthcare

Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in

Digital technologies can improve patients’ attendance of clinical trial appointments, or even reduce the need for regular appointments altogether.

Johnson & Johnson is teaming up with Apple for an important telemedicine initiative. How will their innovative approach impact the future of clinical trials?

Patients, physicians, and researchers all have something to gain from digital health. Here’s how CROs and sponsors can overcome key obstacles to integrate connected technology into clinical trials.

The FDA’s new healthcare app takes a patient-centric approach to collecting data for clinical trials.

New FDA guidelines on electronic health records clear the way for clinical trials to benefit from streamlined patient data.

mHealth is providing researchers with increased opportunities for data collection, patient engagement, and trial recruitment.

New technology promises to increase efficiency and boost patient recruitment, but its adoption is projected to be a slow process. Here’s what CROs and sponsors can expect.

Patient recruitment and retention for clinical trials have always been difficult, but AI and mHealth can help – if sponsors and CROs are willing to invest in them.

A fully digital clinical trial – where patients can participate from the comfort of their home – seems like a pipe dream. But as it turns out, it might not be.